Arginine deprivation therapy for malignant melanoma
Jung-Ki Yoon,1,2 Arthur E Frankel,3 Lynn G Feun,4 Suhendan Ekmekcioglu,1 Kevin B Kim11Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 2Hwasung Public Health Center, Hwasung, South Korea, 3Scott and White Cancer Research Insti...
Guardado en:
Autores principales: | Yoon JK, Frankel AE, Feun LG, Ekmekcioglu S, Kim KB |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b086f0e339804ad6bd801034248563f2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Special issue of clinical pharmacology: advances and applications in new protein therapeutics modulating tumor immunity
por: Frankel AE
Publicado: (2013) -
Use of ipilimumab in the treatment of melanoma
por: Acharya UH, et al.
Publicado: (2013) -
A clinical evaluation to determine the safety, pharmacokinetics, and pharmacodynamics of an inositol-stabilized arginine silicate dietary supplement in healthy adult males
por: Kalman DS, et al.
Publicado: (2015) -
Immunotherapy of melanoma with the immune costimulatory monoclonal antibodies targeting CD137
por: Li SY, et al.
Publicado: (2013) -
Sodium Bicarbonate Nebulized Therapy in Patients with Confirmed COVID-19
por: Jalil Rashedi, et al.
Publicado: (2020)